Phosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function

Paola C Rosas1, Yang Liu1, Mohamed I Abdalla1

  • 1From the Department of Medical Physiology (P.C.R., Y.L., M.I.A., B.M.M., C.W.T.) and Division of Molecular Cardiology, Department of Medicine (C.M.T., R.K., K.M.B.), Texas A&M University Health Science Center, College of Medicine, Temple City; Internal Medicine/Division of Cardiology (D.T.K., C.W.T.) and Department of Surgery (G.F.D., D.M.), Baylor Scott & White Health-Central Texas, Temple City; Department of Cell and Regenerative Biology and Biotechnology Center, University of Wisconsin School of Medicine and Public Health, Madison (P.A.P., D.P.F., R.L.M.); and Department of Physiology and Biophysics and Center for Cardiovascular Research, College of Medicine, University of Illinois, Chicago (B.G.P., C.M.W., R.J.S.).

Insights

Phosphorylation of cardiac myosin-binding protein-C (cMyBP-C) enhances heart muscle relaxation, crucial for treating heart failure with preserved ejection fraction (HFpEF). Deficient cMyBP-C phosphorylation leads to diastolic dysfunction, a hallmark of HFpEF.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Heart failure with preserved ejection fraction (HFpEF) affects nearly 50% of heart failure cases and lacks effective treatments.
  • Diastolic dysfunction is the primary mechanism underlying HFpEF, necessitating research into relaxation-mediating pathways.
  • Cardiac myosin-binding protein-C (cMyBP-C) is a key thick filament protein regulating cross-bridge cycling through its phosphorylation status.

Purpose of the Study:

  • To investigate the functional role of cMyBP-C phosphorylation in regulating myocardial relaxation and diastolic function.
  • To determine if alterations in cMyBP-C phosphorylation contribute to the development of HFpEF phenotypes.
  • To explore cMyBP-C as a potential therapeutic target for HFpEF.

Main Methods:

  • Comparison of mouse models with wild-type, phosphorylation-deficient (t3SA), and phosphomimetic (t3SD) cMyBP-C.
  • Assessment of cardiac function using echocardiography and pressure/volume measurements.
  • Analysis of myocardial relaxation rates and intracellular calcium handling via papillary muscle experiments.

Main Results:

  • Mice with phosphorylation-deficient cMyBP-C (t3SA) exhibited reduced running capacity, increased lung/body weight ratios, and elevated brain natriuretic peptide levels, indicative of heart failure.
  • Phosphorylation-deficient cMyBP-C (t3SA) mice showed impaired myocardial relaxation and diastolic dysfunction, consistent with HFpEF.
  • Phosphomimetic cMyBP-C (t3SD) mice demonstrated enhanced myocardial relaxation, while the underlying mechanism was attributed to altered cross-bridge detachment rates, not changes in calcium handling.

Conclusions:

  • cMyBP-C phosphorylation is essential for enhancing myocardial relaxation and maintaining diastolic function.
  • Deficient cMyBP-C phosphorylation leads to diastolic dysfunction and HFpEF-like phenotypes.
  • Targeting cMyBP-C phosphorylation presents a promising therapeutic strategy for treating HFpEF.
Abstract

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
7.2K
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
125.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
5.1K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.9K